Diseases & Disorders
(G123)
IRS Verified
DX Registered
990 on File
CUREBOUND INC
Financial strength (30%)
93/100
Reliability (20%)
50/100
Effectiveness (25%)
73/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$11.0M
Total Revenue
$14.9M
Total Expenses
$9.0M
Net Assets
21
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
78.9%
Fundraising Efficiency
13.7%
Operating Reserve
7.30x
Liability-to-Asset
23.8%
Revenue Diversification
72.7%
Executive Compensation
$823K
Compared with Peers
FY 2025
Compared with 105 similar organizations
(United States, Diseases & Disorders, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
78.9% | 85.4% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
11.4% | 11.1% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
9.8% | 1.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
13.7% | 368.9% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
7.3 mo | 10.0 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
23.8% | 23.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
72.7% | 92.0% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
99.8% | 7.9% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
38.2% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-35.4% | 3.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $11.0M | $14.9M | $9.0M | 78.9% | 21 |
| 2024 | $5.5M | $10.7M | $12.9M | 78.8% | 14 |
| 2023 | $10.4M | $12.5M | $18.2M | 79.1% | 12 |
| 2022 | $19.8M | $6.2M | $20.3M | 74.6% | 11 |
| 2021 | $8.8M | $2.8M | $6.7M | 67.5% | 7 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.